In tests using dogs with ectopic ventricular tachycardia resulting from myocardial infarction, procaine has been found to be without practical value as an ectopic impulse suppressor agent. Procaine amide has proved to be very effective in reducing the ectopic rate of high frequency tachycardias to low levels, thus eliminating danger of death from the tachycardia. Procaine amide usually does not produce an entirely normal rhythm but this is of little practical importance. The toxicitv of procaine amide is relatively low. For approximately equivalent results, in the tachycardias studied, the dosage of procaine amide must be two to three times that of quinidine.
T HE DEVELOPMENT of a standard technic for producing rapid ectopic ventricular tachycardia associated with myocardial infarction in dogs' has provided a valuable preparation for studies upon the nature and treatment of this kind of arrhythmia.
Comparison of the types of ventricular arrhythmias that develop in association with myocardial infarction in dogs with those found in a large series of patients2 with myocardial infarction, and comparisons of the reactions of dogs and men exhibiting these ventricular arrhythmias to intravenous quinidine have revealed striking similarities.3 These similarities appear to justify confidence that results obtained in the dog with myocardial infarction and ectopic ventricular tachycardia can be valuable in deriving principles which would be of value as guides to improvement in the management of patients with ventricular arrhythmias resulting from this cause. Reports from investigations upon the effects of diphenylhydantoin sodium (Dilantin) and pheno- The experiments to be reported were planned for the purpose of critically evaluating procaine and procaine amide (Pronestyl) as suppressors of ectopic ventricular tachycardia associated with myocardial infarction. Mautz6 demonstrated that locally applied procaine, Metycaine, cocaine and potassium chloride significantly increase the electrical threshold for extrasystoles at a constant time in diastole. In another paper7 Mautz reported that the use of intravenous and locally applied procaine aids in the resuscitation of the heart from ventricular fibrillation by the use of the electric defibrillator and massage. As a result of these studies, the use of procaine prophylactically during surgery in the region of the heart has been recommended. 8 Wiggers duced significant diminutions of ectopic frequency but they were of short duration. Each dose had produced convulsions.
Morphine, 5 mg. per kilogram, was administered subcutaneously one and one-half hours after the fourth dose of procaine. No significant change in ectopic rate occurred in the first 30 minutes after the morphine. Three additional doses of procaine produced effects that were generally similar to the results of procaine administration before morphine, including convulsions. Another dose of morphine was followed by another dose of procaine, but within 30 minutes after the last dose the ectopic rate had risen again to 170 to 180, the highest level of the day. animals. The ectopic suppressor effect of procaine was not improved by the addition of morphine, nor were the convulsive reactions prevented.
The chart reproduced in figure 1 serves to illustrate the effects of procaine alone and in combination with large amounts of morphine. The ectopic suppressor effect of procaine (alone) was more evident in this experiment than was usual in the series. The control ectopic rate during the two hours just preceding the first dose of procaine was 130 to 160 per minute, relatively low frequency ventricular tachycardia. The first two doses of procaine (20 mg. per kilogram) produced a marked reduction in ventricular ectopic rate. Before the third dose was administered, however, the ectopic rate had risen to a level higher than that of the control period. Each of the next two doses also proocclusion) the ectopic rate was 180. Morphine, 5 mg. per kilogram, was injected. This was followed 30 minutes later by procaine. The ectopic rate fell to 0 at the end of the procaine injection, but after five minutes it had risen again to 150, after which it fluctuated between 170 and 190. Another dose of procaine produced a drop to 100 followed by another quick rise to 150 to 170. Each dose was followed by convulsions as before.
In the other experiments, including those in which convulsions did not occur, the ectopic suppressor effects were as feeble and as fleeting as in the one illustrated. It must be concluded that procaine with or without morphine has no practical value as an agent for the suppression of ectopic ventricular tachycardia produced by myocardial infarction. 5`53 Procaine Amide (Pronestyl)*
The effects of procaine amide alone were determined in 12 tests in eight animals. Morphine was administered prior to the first dose of procaine amide in three tests in three animals.
The electrocardiographic results of the administration of procaine amide to an animal with a very high frequency ectopic ventricular tachycardia is illustrated by figure 2. The control record, made on the morning of the first postocclusion day, 18 hours after the operation, shows a ventricular ectopic rate of 300 per minute. Immediately after completion of the five-minute injection of the first dose (40 mg. per kilogram) many beats of normal origin I:
HEART RATE i3-ECTPIC RATE 0---tively low (10 to 110) without additional doses during the balance of the day of observations, more than nine hours. By the following morning the ectopic rate had risen to 170 and the rhythm again was totally ectopic. An injection of procaine amide, 40 mg. per kilogram, reduced the ectopic activity to a low level during the next 30 minutes, after which it tended to stabilize at a rate of 70 to 80. A second dose had much less effect than the first, and a large increase in ectopic activity began after about 30 minutes. Two later doses produced restlessness and vomiting, and had relatively little ectopic suppressor action. Vomiting was not observed in any other experiment. were present and the ectopic rate was reduced to 80 (second record). The third record, made five and three-quarters hours after the first injection, and four hours after the last injection, shows that some ectopic activity still persisted at a safely low frequency along with many normal complexes. The total amount of procaine amide administered was 120 mg. per kilogram.
More complete data from the same experiment was presented in the chart reproduced in figure 3 . The administration of procaine amide, 120 mg. per kilogram, during a period of one and three-quarters hours reduced the ectopic rate from 300 to 0. The complete elimination of ectopic complexes lasted for a few minutes only, but the ectopic frequency remained rela-* The procaine amide used in this study was generously supplied by E. R. Squibb and Sons.
An experiment that showed a somewhat different type of reaction to procaine amide is presented in the chart reproduced in figure 4 shows that even in a relatively insensitive animal, doses of procaine amide can not be increased indefinitely. In this animal, ectopic activity was never completely eliminated for more than a few minutes at a time.
Experiment C-282. Morphine, 5 mg. per kilogram, was followed after an interval of 45 minutes by the first of five 30 mg. per kilogram doses of procaine amide. These were followed by one 40 mg. per kilogram dose. All doses of procaine amide were given at intervals of 30 minutes. Each dose was followed by a decline of mean blood pressure of 5 to 20 mm. Hg. The animal survived and was in good condition until sacrificed some days later. Low frequency (20 to 50 per minute) ectopic complexes returned between doses, but failed to recur after the last one.
Experiment C-283. Morphine, 5 mg. per kilogram, was followed after an interval of 45 minutes by the first dose of procaine amide. Five doses of equal size, 30 mg. per kilogram, were administered at 30 to 45 minute intervals. After each of the first three doses of procaine amide there was a sharp drop in mean pressure of 20 to 30 mm. Hg, and the control level was not fully regained between doses. The fourth dose produced a fall of 55 mm., from which there was little recovery during the next 30 minutes. The fifth dose was followed by a fall to 0, intraventricular block, terminal ventricular fibrillation and death. This animal was definitely more sensitive to the depressor effects than were the other two.
Study of the protocols does not reveal the cause of the greater vulnerability of this animal. One of the two less sensitive animals also received morphine, 5 mg. per kilogram. The one dog in the entire series that died after the smallest amount of procaine amide (2 doses, 30 mg. per kilogram each) had received no morphine at all. Unfortunately no blood pressure measurements were made on this animal.
Duration of QRS Complexes and of P-R Intervals. In 7 of the 10 dogs, prolongation of the QRS complexes in normally initiated beats was small, remaining below 30 per cent of the control durations throughout the testing procedures. One of these seven dogs with minimal prolongation died after the second 30 mg. per kilogram dose of procaine amide.
Prolongation of QRS by 75 to 100 per cent occurred in three animals. Two of these three animals with a definite prolongation by this amount died.
Variations in the P-R interval bore no relation to dosage or to QRS in seven animals. These included the animal in which failure of the pacemaker and cardiac standstill followed the second dose; the P-R interval was prolonged by no more than 20 per cent (0.10 to 0.12) by the first dose. This is within the limits of spontaneous variation.
There was a significant widening of P-R associated with widening of QRS in the other two fatality cases.
Fatalities. There were three deaths during testing. Widening of the QRS complex sufficient to constitute a warning sign existed prior to the last dose in two animals. In the other case, the animal that died soon after the second dose, the greatest width of QRS after the first dose was 0.05 second compared with 0.04 before treatment.
Study of the protocols of these three animals for other observations that might serve as warning signs revealed only that one dog, the animal most sensitive to procaine amide, was quiet and listless prior to the first dose, and its indifference to surroundings became more pronounced after the first dose was given.
DISCUSSION
Procaine. It has been demonstrated that although intravenous procaine has some ectopic impulse suppressor action, its effective duration is too brief to be of practical value for the treatment of ectopic ventricular tachycardias associated with myocardial infarction. Its tendency to induce convulsions also renders its use in the unanesthetized state objectionable.
Procaine Amide. The experiments have shown that procaine amide is very effective in reducing the frequency of rapid ectopic ventricular tachycardias to relatively low frequency ectopic beats mixed with normal complexes. Usually it has not eliminated all ectopic activity although many additional doses and larger doses were administered after the major reduction in ectopic frequency had been produced. In some experiments with low frequency ectopic activity prior to the beginning of treatment, procaine amide has had little effect on the ectopic activity. In at least one test with a low ectopic frequency, however, one dose permanently restored a completely normal rhythm. These and certain other drugs used for the control of ventricular ectopic rhythms, it should be remembered that one very quiet animal died after only two doses of procaine amide of a size that was well tolerated in the majority of animals though repeated many times. One other dog died after the administration of an amount of procaine amide that may be regarded as being well within the usual therapeutic range of total dosage during a period of a few hours. The third death occurred only after excessive dosage.
The observations upon two of these dogs suggest that, during treatment of severe ventricular tachyeardias with procaine amide, some of the principles which were developed from the observations of the reactions of such dogs to the intravenous administration of quinidine lactate and quinidine gluconate3 should be applied. In those experiments the animals with hypotension and dyspnea tended to be most sensitive to the drug, and to die after administration of relatively small amounts. In all cases of severe ectopic ventricular tachycardia only that amount of drug which is required to reduce the ectopic rate to a safely low range and to maintain it at a low level should be administered. Eventually the harmless low frequency ectopic beats will cease spontaneously. In all cases of severe ectopic ventricular tachycardia, an electrocardiograph machine, preferably a directwriting type, should be kept near the patient and used at frequent intervals as a guide to therapy. These experiments indicate that in order to produce equivalent ectopic suppressor effects in ectopic ventricular tachycardias accompanying acute myocardial infarction the dosage of procaine amide should be two to three times that of quinidine lactate or glu- It is deduced that in myocardial infarction multiple ectopic excitatory factors probably are active, and that the major factor in high frequency tachyeardias is opposed by procaine amide.
The elimination of danger of ventricular fibrillation and a marked improvement in the effectiveness of pumping are achieved by the reduction of the ectopic frequency to low levels. Since such a reduction can be produced by doses of procaine amide that usually produce a little or no toxic reaction, it is regarded as a promising suppressor agent for use in severe ectopic ventricular tachyeardias.
